Inventor · disambiguated record
Elizabeth Woldemussie
Also filed as: WOLDEMUSSIE ELIZABETH
19 granted patents·7 pending applications·885 citations·filing 1992–2018
96Inventor score
Top patents by PatentIndex Score
26 records- 0197US6248741B1Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injuryALLERGAN SALES INC·Filed 2000·Granted Jun 19, 2001·98 cites·11 claims
- 0297US6194415B1Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injuryALLERGAN SALES INC·Filed 1999·Granted Feb 27, 2001·168 cites·6 claims
- 0396US6465464B2Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injuryALLERGAN INC·Filed 2002·Granted Oct 15, 2002·72 cites·16 claims
- 0495US6410544B1Cholinergic agents in the treatment of presbyopiaALLERGAN SALES INC·Filed 2001·Granted Jun 25, 2002·74 cites·13 claims
- 0591US6164282AMethods for restoring and/or enhancing accommodation in pseudo phakiaALLERGAN SALES INC·Filed 1999·Granted Dec 26, 2000·106 cites·20 claims
- 0687US6291466B1Cholinergic agents in the treatment of presbyopiaALLERGAN SALES INC·Filed 1998·Granted Sep 18, 2001·62 cites·4 claims
- 0784US5925342AMethod for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockersALLERGAN INC·Filed 1997·Granted Jul 20, 1999·90 cites·6 claims
- 0883US5716952AMethod for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonistsALLERGAN INC·Filed 1992·Granted Feb 10, 1998·49 cites·8 claims
- 0980US5856329AMethod of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injuryALLERGAN INC·Filed 1995·Granted Jan 5, 1999·50 cites·15 claims
- 1077US5573758AMethod for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockersALLERGAN INC·Filed 1995·Granted Nov 12, 1996·52 cites·10 claims
- 1172US5559151AMethod for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockersALLERGAN INC·Filed 1994·Granted Sep 24, 1996·20 cites·10 claims
- 1271US5705530AMethod for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockersALLERGAN INC·Filed 1996·Granted Jan 6, 1998·22 cites·12 claims
- 1363US8541426B2Pharmaceutical compositions and methods of treating dry eye disordersBEALS CHANNING R·Filed 2008·Granted Sep 24, 2013·1 cites·10 claims
- 1454US8455492B2Methods for treating retinal diseasesWHEELER LARRY A·Filed 2005·Granted Jun 4, 2013·0 cites·10 claims
- 1554US2002183328A1Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injuryALLERGAN SALES INC·Filed 2002·Application pending·0 cites
- 1652US2001046998A1Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injuryALLERGAN SALES INC·Filed 2001·Application pending·0 cites
- 1751US2021000972A1Nanoparticles for sustained ophthalmic drug delivery and methods of use2C TECH CORP·Filed 2018·Application pending·0 cites
- 1849US2018207293A1Nanoparticles for sustained ophthalmic drug delivery and methods of use2C TECH CORP·Filed 2017·Application pending·0 cites
- 1947US2006264442A1Methods for the treatment of ocular and neurodegenerative conditions in a mammalALLERGAN INC·Filed 2005·Application pending·0 cites
- 2046US5891911AMethod for reducing intraocular pressure in the mammalian eye by administration of calcium chelatorsALLERGAN INC·Filed 1995·Granted Apr 6, 1999·9 cites·6 claims
- 2146US2013303557A1Pharmaceutical compositions and methods of treating dry eye disordersPFIZER·Filed 2013·Application pending·0 cites
- 2244US6077839AMethod for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonistsALLERGAN SALES INC·Filed 1992·Granted Jun 20, 2000·5 cites·7 claims
- 2343US2007212395A1Ocular therapy using sirtuin-activating agentsALLERGAN INC·Filed 2006·Application pending·0 cites
- 2439US5866605AMethod for providing a neuroprotective effect to the mammalian eye by administration of chloride channel blockersALLERGAN INC·Filed 1997·Granted Feb 2, 1999·2 cites·3 claims
- 2536US5677327AMethod for identifying muscarinic agents lacking miotic side effectsALLERGAN INC·Filed 1995·Granted Oct 14, 1997·4 cites·2 claims
- 2630US5521210AOphthalmic use of muscarinic agonists having increased duration of activityALLERGAN INC·Filed 1993·Granted May 28, 1996·1 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Elizabeth Woldemussie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →